OMGA – omega therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Omega Therapeutics, Inc. (NASDAQ: OMGA) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.
Omega Therapeutics, Inc. (NASDAQ: OMGA) had its price target lowered by analysts at Piper Sandler from $9.00 to $4.00. They now have an "overweight" rating on the stock.
Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results
Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings
Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications
Form 4 Omega Therapeutics, Inc. For: Nov 15 Filed by: Certel Kaan
Form 8-K Omega Therapeutics, Inc. For: Nov 14
Form 10-Q Omega Therapeutics, Inc. For: Sep 30
Form 4 Omega Therapeutics, Inc. For: Oct 02 Filed by: Rosiello Robert L.
Form 3 Omega Therapeutics, Inc. For: Oct 02 Filed by: Rosiello Robert L.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.